End-of-Life Care Preferences of Patients with Advanced Urological Malignancies: An Explorative Survey Study at a Tertiary Referral Center

• Published in: Current oncology (Toronto) 2024-01, Vol.31 (1), p.462-471
• Main Authors: Volberg, Christian, Urhahn, Fabian, Pedrosa Carrasco, Anna J, Morin, Astrid, Gschnell, Martin, Huber, Johannes, Flegar, Luka, Heers, Hendrik
• Format: Article
• Language: English
• Subjects: Cancer; Carcinoma, Transitional Cell; end of life; Female; Humans; Kidney Neoplasms - therapy; Male; Medical personnel; palliative care; Palliative treatment; patient preference; place of death; Prostate cancer; Surveys; Terminal Care; Tertiary Care Centers; Urinary Bladder Neoplasms - therapy; urological malignancies
• ISSN: 1718-7729; 1198-0052; 1718-7729
• DOI: 10.3390/curroncol31010031

Many people want to die at home, but it is often not possible because they do not share their wishes with family members. This study was conducted to find out the extent to which patients with advanced urological malignancies had wishes regarding their final stage of life, made arrangements accordingly, and communicated their wishes to relatives and health care professionals. We conducted a survey among advanced urological tumor patients during their clinic visit at a German university hospital using a 31-item questionnaire. Inclusion criteria were metastatic or irresectable prostate cancer, urothelial carcinoma, or renal cell carcinoma. In total, 88 patients (76 male, 12 female) completed the questionnaire, and 62 of those respondents (70%) had received their tumor diagnosis within the past 5 years. Symptoms were reported by 80%, and 18% described five or more symptoms. The majority (88%) stated that they had thought about their preferred place of death but 58% had not informed anyone about it. The preference for a hospice as the place of death correlated statistically significantly with the absence of a domestic partnership ( = 0.001) or marriage ( < 0.001) and with a high number of symptoms (≥5; = 0.009). However, 73% had not talked with their urological oncologist about care options in case their health deteriorated though 36% of those were interested in having a conversation about it. Our results showed that 9 out of 10 patients reflected on their preferred place of death but only a few discussed it with anyone. Based on this finding, physicians and healthcare staff should initiate discussions about early care planning so that patients in incurable situations can express their wishes regarding their preferred place of death.